Chinese Professional Dicocodimonium Chloride - Other Protected Amino Acids for Disulfide bond – Gentolex

Short Description:

Send email to us

Product Detail

Product Tags

Feedback (2)

Our company has been focusing on brand strategy. Customers' satisfaction is our best advertising. We also supply OEM service for Lupeol Acetate, Raw Material, Iron 2 Acetate, We welcome shoppers, business enterprise associations and close friends from all sections with the globe to contact us and seek cooperation for mutual added benefits.

Chinese Professional Dicocodimonium Chloride - Other Protected Amino Acids for Disulfide bond – Gentolex Detail:

Product Detail

NO	Products	CAS No	Application	Key Quality Indicator
NO	Products	CAS No	Application	Purity	Isomer	Specific impurity	*Max1	Moisture
1	Fmoc-Cys(Acm)-OH	86060-81-3	Disulfide bond	≥99.0%	≤0.1%	≤0.1%	≤0.2%	≤1.0%
2	Fmoc-Cys(Mmt)-OH	177582-21-7	Disulfide bond	≥98.0%	≤0.2%	≤0.3%	≤0.5%	≤1.0%
3	Fmoc-Cys(4-allylbutyrate)-OH	/	Disulfide bond	≥98.0%	≤0.2%	≤0.3%	≤0.5%	≤1.0%
4	Mpa(Trt)-OH	27144-18-9	End of sequence	≥99.5%	/	≤0.1%	≤0.2%	≤1.0%
5	Fmoc-Thr(tBu)-OL	189337-28-8	Octreotide	≥97.0%	≤0.3%	≤0.5%	≤1.0%	≤1.0%
6	Fmoc-D-Arg(pbf)-OH	187618-60-6	Desmopressin	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤2.0%
7	Fmoc-Gly-Gly-OH	35665-38-4	Bivalirudin	≥99.5%	/	≤0.1%	≤0.2%	≤1.0%
8	Fmoc-Gly-Gly-Gly-OH	170941-79-4	Terlipressin	≥99.5%	/	≤0.1%	≤0.2%	≤1.0%
9	Fmoc-Gly-Gly-Gly-Gly-OH	/	Bivalirudin	≥99.5%	/	≤0.1%	≤0.2%	≤1.0%
10	Fmoc-Gly-Asp(tBu)-OH	/	Bivalirudin	≥99.5%	/	≤0.15%	≤0.2%	≤1.0%
11	Boc-Cys(Trt)-OH	21947-98-8	End of sequence	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
12	Boc-Arg(pbf)-OH	200124-22-7	End of sequence	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
13	Boc-Ala-OH	15761-38-3	End of sequence	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
14	Boc-D-Phe-OH	18942-49-9	End of sequence	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
15	Boc-Gly-OH	4530-20-5	End of sequence	≥99.5%	/	≤0.1%	≤0.2%	≤1.0%
16	Boc-Lys(Boc)-OH.DCHA	15098-69-8	End of sequence	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
17	Boc-Ser(tBu)-OH	7738-22-9	End of sequence	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
18	Boc-Thr(tBu)-OH	13734-40-2	End of sequence	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
19	Boc-D-Ala-OH	7764-95-6	End of sequence	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
20	Boc-Met-OH	2488-15-5	End of sequence	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
21	Boc-Tyr(tBu)-OH	47375-34-8	End of sequence	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
22	Boc-D-Arg(pdf)-OH	187618-60-6	End of sequence	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
23	Boc-Asp(OtBu)-OH.DCHA	1913/12/8	End of sequence	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
24	Fmoc-HomoArg(pbf)-OH	1159680-21-3	Eptifibatide	≥98.5%	≤0.2%	/	≤0.5%	≤2.0%
25	Fmoc-Asp-OtBu	129460-09-9	Thymalfasin	≥99.5%	≤0.1%	≤0.1%	≤0.2%	≤1.0%
26	Fmoc-Tyr(Me)-OH	77128-72-4	Carbetocin	≥98.5%	≤0.2%	≤0.3%	≤0.5%	≤1.0%
27	Fmoc-Orn(Boc)-OH	109425-55-0	Atosiban Omnipressin Daptomycin	≥99.5%	≤0.1%	≤0.1%	≤0.2%	≤2.0%
28	Fmoc-D-Tyr(Et)-OH	162502-65-0	Atosiban	≥99.5%	≤0.1%	≤0.1%	≤0.2%	≤1.0%
29	Fmoc-Asp(OAll)-OH	146982-24-3	Melanotan	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
30	Ac-Nle-OH	15891-49-3	Melanotan	≥99.0%	/	≤0.3%	≤0.3%	≤1.0%
31	Fmoc-Nle-OH	77284-32-3	Melanotan Afamelanotide	≥99.0%	/	≤0.3%	≤0.3%	≤1.0%
32	Ac-Glu(OtBu)-OH	84192-88-1	Argireline Acetyl octapeptide-3	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
33	Ac-β-Ala-OH·DCHA	/	Acetyl tetrapeptide-5	≥99.0%	/	≤0.3%	≤0.3%	≤1.0%
34	Fmoc-ß-Ala-OH	35737-10-1	Acetyl tetrapeptide-5	≥99.5%	/	≤0.1%	≤0.2%	≤1.0%
35	Fmoc-Hyp(tBu)-OH	122996-47-8	Icatibant	≥98.0%	≤0.2%	≤0.3%	≤0.5%	≤1.0%
36	Fmoc-Thi-OH	130309-35-2	Icatibant	≥98.0%	≤0.2%	≤0.3%	≤0.5%	≤1.0%
37	Fmoc-D-Tic-OH	130309-33-0	Icatibant	≥98.0%	≤0.2%	≤0.3%	≤0.5%	≤1.0%
38	Fmoc-Oic-OH	130309-37-4	Icatibant	≥98.0%	≤0.2%	≤0.3%	≤0.5%	≤1.0%
39	Boc-Sar-OH	13734-36-6	Saralasin	≥98.0%	≤0.2%	≤0.3%	≤0.5%	≤1.0%
40	Fmoc-Sar-OH	77128-70-2	Saralasin	≥98.0%	≤0.2%	≤0.3%	≤0.5%	≤1.0%
41	Fmoc-Tyr(SO3Na)-OH.H2O	106864-37-3	Sincalide	≥98.0%	≤0.2%	≤0.3%	≤0.5%	≤1.0%
42	Fmoc-D-Asp(OtBu)-OH	112883-39-3	Daptomycin	≥98.5%	≤0.2%	≤0.3%	≤0.5%	≤1.0%
43	Ac-Ser(tBu)-OH	77285-09-7	Afamelanotide	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
44	Boc-HomoCys(Trt)-OH	201419-16-1	Depreotide	≥98.0%	≤0.2%	≤0.3%	≤0.5%	≤1.0%
45	Fmoc-HomoCys(Trt)-OH	167015-23-8	Depreotide	≥98.0%	≤0.2%	≤0.3%	≤0.5%	≤1.0%
46	Fmoc-Dab-OH	161420-87-7	Snake venom	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%

*Max1 = Max Unknown Purity

Other Indicator:

- Acetic Acid: ≤0.02% (All Products)

- Ethyl Acetate: ≤0.5% (All Products)

- Alcohol: ≤0.5% (All Products)

- Max Unknow Impurity: Fmoc-Trp(Boc)-OH (143824-78-6) ≤0.3%; Others ≤0.2%

Product detail pictures:

Related Product Guide:

Our firm promises all consumers with the first-class products as well as most satisfying post-sale services. We warmly welcome our regular and new consumers to join us for Chinese Professional Dicocodimonium Chloride - Other Protected Amino Acids for Disulfide bond – Gentolex , The product will supply to all over the world, such as: Poland, Malaysia, Iran, We solution have passed through the national skilled certification and been well received in our key industry. Our specialist engineering team will often be ready to serve you for consultation and feedback. We are able to also provide you with no cost samples to meet your needs. Best efforts will be produced to offer you the very best service and solutions. For anyone who is considering our business and solutions, please speak to us by sending us emails or get in touch with us right away. As a way to know our products and enterprise. lot more, you'll be able to come to our factory to find out it. We will constantly welcome guests from around the globe to our firm. o build enterprise. elations with us. Please really feel absolutely free to make contact with us for small business and we believe we will share the top trading practical experience with all our merchants.

4-Methylaminophenol Sulfate

Acetyl Carnitine Hcl

Aclidinium Bromide

Carbetocin Pharmacology

Cholesteryl Acetate

Cobalt 2 Acetate

Daptomycin_103060-53-3

Glycerol Acetate

Penta Acetate

Sodium Thioglycolate

The customer service reprersentative explained very detailed, service attitude is very good, reply is very timely and comprehensive, a happy communication! We hope to have a opportunity to cooperate.